blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3122339

EP3122339 - EFFECT OF LIPOPHILIC NUTRIENTS ON DIABETIC EYE DISEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.01.2022
Database last updated on 12.10.2024
FormerExamination is in progress
Status updated on  30.03.2019
FormerRequest for examination was made
Status updated on  30.12.2016
FormerThe international publication has been made
Status updated on  16.11.2016
Most recent event   Tooltip07.01.2022Application deemed to be withdrawnpublished on 09.02.2022  [2022/06]
Applicant(s)For all designated states
Omniactive Health Technologies Ltd.
T-8b, 5th Floor, Phoenix House A wing, Phoenix Mills Compound
462, Senapati Bapat Marg
Lower Parel
Mumbai - 400013 / IN
[2017/05]
Inventor(s)01 / DESHPANDE, Jayant
OmniActive Health Technologies (Canada) Limited
62, Crestwood Drive
Charlottetown, Prince Edward Island C1A 3H5 / CA
02 / JEYAKODI, Shankaranarayanan
OmniActive Health Technologies Limited
New Technology Centre
Plot No. A-10
Road No. 1, Wagle Industrial Estate, Thane (w)
Maharashtra 400 604 / IN
 [2017/05]
Representative(s)Cabinet Beau de Loménie
158, rue de l'Université
75340 Paris Cedex 07 / FR
[N/P]
Former [2017/05]Nevant, Marc, et al
Cabinet Beau de Loménie 158, rue de l'Université
75340 Paris Cedex 07 / FR
Application number, filing date15717249.526.03.2015
[2017/05]
WO2015IB52248
Priority number, dateIN2014MUM112828.03.2014         Original published format: IN 1128MU2014
[2017/05]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2015145389
Date:01.10.2015
Language:EN
[2015/39]
Type: A2 Application without search report 
No.:EP3122339
Date:01.02.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 01.10.2015 takes the place of the publication of the European patent application.
[2017/05]
Search report(s)International search report - published on:EP26.11.2015
ClassificationIPC:A61K31/047, A61K36/9066, A61K36/9068, A61K47/00, A61K31/09, A61P27/12, A61P27/02
[2017/05]
CPC:
A61K31/12 (EP,US); A23L33/105 (EP,KR,US); A61K36/9066 (EP,CN,KR,US);
A61K31/047 (EP,CN,KR,US); A61K31/09 (EP,CN,KR,US); A61K36/9068 (EP,CN,KR,US);
A61K47/00 (EP,US); A61K47/10 (EP,CN,KR,US); A61K47/20 (EP,CN,US);
A61K47/22 (EP,CN,KR,US); A61K47/26 (EP,CN,US); A61K47/32 (EP,CN,US);
A61K47/36 (EP,CN,US); A61K47/38 (EP,CN,US); A61K47/44 (EP,CN,KR,US);
A61K9/0053 (EP,CN,KR,US); A61K9/0056 (US); A61P27/02 (EP);
A61P27/12 (EP); A61P3/10 (EP); A61P9/10 (EP);
A23V2002/00 (KR,US); A23V2200/328 (KR) (-)
C-Set:
A61K31/047, A61K2300/00 (CN);
A61K31/09, A61K2300/00 (CN);
A61K36/9066, A61K2300/00 (CN);
A61K36/9068, A61K2300/00 (CN)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/05]
TitleGerman:WIRKUNG VON LIPOPHILEN NÄHRSTOFFEN AUF DIABETISCHE AUGENERKRANKUNGEN[2017/05]
English:EFFECT OF LIPOPHILIC NUTRIENTS ON DIABETIC EYE DISEASES[2017/05]
French:EFFET DE NUTRIMENTS LIPOPHILES SUR DES MALADIES DES YEUX LIÉES AU DIABÈTE[2017/05]
Entry into regional phase14.10.2016National basic fee paid 
14.10.2016Designation fee(s) paid 
14.10.2016Examination fee paid 
Examination procedure28.01.2016Request for preliminary examination filed
International Preliminary Examining Authority: EP
14.10.2016Amendment by applicant (claims and/or description)
14.10.2016Examination requested  [2017/05]
14.10.2016Date on which the examining division has become responsible
03.04.2019Despatch of a communication from the examining division (Time limit: M06)
04.10.2019Reply to a communication from the examining division
29.05.2020Despatch of a communication from the examining division (Time limit: M04)
22.09.2020Reply to a communication from the examining division
26.04.2021Despatch of a communication from the examining division (Time limit: M04)
07.09.2021Application deemed to be withdrawn, date of legal effect  [2022/06]
28.09.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2022/06]
Fees paidRenewal fee
27.03.2017Renewal fee patent year 03
23.03.2018Renewal fee patent year 04
26.03.2019Renewal fee patent year 05
24.03.2020Renewal fee patent year 06
23.03.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]CN103238902  ;
 [Y]CN102225087  ;
 [Y]US3998753  (ANTOSHKIW THOMAS WILLIAM, et al) [Y] 1-17 * in particular * * Summary of the Invention * * column 2, paragraphs 1, 4, 5, 6 * * column 4, line 25 - line 32 * * Examples * * Claims *;
 [YP]WO2014155189  (OMNIACTIVE HEALTH TECHNOLOGIES LTD [IN]) [YP] 1-17 * page 1 - page 17 ** Claims *;
 [Y]  - P. SURYANARAYANA, "Curcumin and Turmeric Delay Streptozotocin-Induced Diabetic Cataract in Rats", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, (20050601), vol. 46, no. 6, doi:10.1167/iovs.04-1304, ISSN 0146-0404, pages 2092 - 2099, XP055052633 [Y] 1-17 * the whole document * * in particular * * abstract * * Results * * Discussion *

DOI:   http://dx.doi.org/10.1167/iovs.04-1304
 [Y]  - BROWN, L. ET AL, "A prospective study of carotenoid intake and risk of cataract extraction in US men", AMERICAN JOURNAL OF CLINICAL NUTRITION, (19991001), vol. 70, no. 4, pages 517 - 524, XP002742194 [Y] 1-17 * the whole document * * in particular * * abstract * * Results * * Discussion *
 [Y]  - RALF JÄGER ET AL, "Comparative absorption of curcumin formulations", NUTRITION JOURNAL, BIOMED CENTRAL, GB, (20140124), vol. 13, no. 1, doi:10.1186/1475-2891-13-11, ISSN 1475-2891, page 11, XP021175910 [Y] 1-17 * the whole document * * in particular * * abstract * * Results * * Discussion * * Conclusion *

DOI:   http://dx.doi.org/10.1186/1475-2891-13-11
 [Y]  - Anonymous, "CurcuWIN(TM) Officially Launched at Engredea 2014 - OmniActive", (20140225), URL: http://www.omniactives.com/news/press-releases/curcuwin-officially-launched-at-engredea-2014, (20150701), XP055199513 [Y] 1-17 * the whole document *
 [Y]  - Stephen Daniells, "OmniActive's curcumin shows 46-fold bioavailability increase compared to standard curcumin: Study", (20140203), Nutraingredients-Usa.Com, URL: http://www.nutraingredients-usa.com/Research/OmniActive-s-curcumin-shows-46-fold-bioavailability-increase-compared-to-standard-curcumin-Study, (20150701), XP055199515 [Y] 1-17 * the whole document *
 [XY]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2014, no. 01, Database accession no. 2013-U63219, XP002742195 & CN103238902 A 20130814 (YUNNAN RAINBOW BIO TECH CO LTD) [X] 1-17 * abstract * [Y] 1-17
 [Y]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2012, no. 24, Database accession no. 2011-P56923, XP002742196 & CN102225087 A 20111026 (LEI A) [Y] 1-17 * the whole document *
 [XP]  - Shankaranarayanan J. et al, "Soluble Curcumin (CurcuwinTM) in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways -- in vivo model", (20141015), 55th Annual Conference. Translational Nutrition: --Turning Research into Practice in Partnership with Scripps Health, URL: http://www.researchgate.net/publication/267156372_SOLUBLE_CURCUMIN_%28CURCUWIN%29_IN_THE_PREVENTION_OF_DIABETIC_RETINOPATHY_VIA_MODULATION_OF_ANTI-OXIDANT_ACTIVITY_AND_GENETIC_PATHWAYS__IN_VIVO_MODEL, (20150714), XP002742197 [XP] 1-17 * the whole document *
 [XP]  - N J Morristown, "OMNIACTIVE PRESENTS STUDY ON LUTEIN'S ROLE IN VISIUAL FUNCTION AND RETINALDAMAGE IN DIABETES MODELS", UtahSoluble Lutein, (20140728), URL: http://www.omniactives.com/news-pdfs/117-PR_140728_OAHT_Presents_Study_on_Lutein_Role_in_Visual_Function_FINAL.pdf, (20150706), XP055200195 [XP] 1-17 * the whole document *
ExaminationWO2011027209
    - RAVIKRISHNAN R ET AL, "Safety assessment of lutein and zeaxanthin (Lutemax 2020): Subchronic toxicity and mutagenicity studies", FOOD AND CHEMICAL TOXICOLOGY, PERGAMON, GB, vol. 49, no. 11, doi:10.1016/J.FCT.2011.08.011, ISSN 0278-6915, (20110809), pages 2841 - 2848, (20110822), XP028308250

DOI:   http://dx.doi.org/10.1016/j.fct.2011.08.011
by applicantUS6737535
 US6743953
 WO2010032267
 CA2760932
 CN102178925
 EP2618832
    - THURNHAM D, "Carotenoids: function and fallacies", PROC NUTR SOC, (1994), vol. 53, pages 77 - 87
    - COLEMAN H; CHEW E., "Nutritional supplementation in age-related macular degeneration", CURR OPIN OPHTHALMOL, (2007), vol. 18, no. 3, pages 220 - 223
    - BILLSTEN ET AL., "Photophysical Properties of Xanthophylls in Caroteno proteins from Human Retina", PHOTOCHEMISTRY AND PHOTOBIOLOGY, (2003), vol. 78, pages 138 - 145
    - SASAKI ET AL., IOVS, (200903), vol. 50, no. 3
    - "Method 970.64", ., AOAC, 16th ed.
    - HADDEN ET AL., J.AGRIC.FOOD.CHEM, (1999), vol. 47, pages 4189 - 494
    - SURYANARAYANA P ET AL., "Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats", INVEST OPHTHALMOL VIS SCI, (2005), vol. 46, no. 6, pages 2092 - 9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.